Business Description
3D Medicines Inc
ISIN : KYG8872R1011
Total Employee Number:
162Compare
Compare
Traded in other countries / regions
01244.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2022-12-15Description
3D Medicines Inc is an investment holding company. The company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products.It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life. It generates all of its revenue from China. Its commercialized product is Envita.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.87 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -0.93 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -6.1 | |||||
Beneish M-Score | -0.24 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -51.4 | |||||
3-Year EBITDA Growth Rate | 69.1 | |||||
3-Year EPS without NRI Growth Rate | 67.7 | |||||
3-Year FCF Growth Rate | 55.6 | |||||
3-Year Book Growth Rate | -13.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.68 | |||||
9-Day RSI | 36.81 | |||||
14-Day RSI | 37.45 | |||||
3-1 Month Momentum % | -18.92 | |||||
6-1 Month Momentum % | -48.53 | |||||
12-1 Month Momentum % | -73.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.45 | |||||
Quick Ratio | 1.44 | |||||
Cash Ratio | 1.14 | |||||
Days Inventory | 38.12 | |||||
Days Sales Outstanding | 55.55 | |||||
Days Payable | 828 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 18.55 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.09 | |||||
Operating Margin % | -20.81 | |||||
Net Margin % | -49.9 | |||||
EBITDA Margin % | -46.26 | |||||
FCF Margin % | -44.4 | |||||
OCF Margin % | -44.39 | |||||
ROE % | -25.67 | |||||
ROA % | -16.34 | |||||
ROIC % | -13.41 | |||||
3-Year ROIIC % | 246 | |||||
ROC (Joel Greenblatt) % | -106.1 | |||||
ROCE % | -28.44 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.26 | |||||
PB Ratio | 0.75 | |||||
Price-to-Tangible-Book | 0.75 | |||||
EV-to-EBIT | -0.54 | |||||
EV-to-EBITDA | -0.59 | |||||
EV-to-Revenue | 0.27 | |||||
EV-to-FCF | -0.61 | |||||
Price-to-GF-Value | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 2.06 | |||||
| Price-to-Net-Cash | 4.58 | |||||
Earnings Yield (Greenblatt) % | -185.19 | |||||
FCF Yield % | -35.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3D Medicines Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 390.939 | ||
| EPS (TTM) (HK$) | -0.792 | ||
| Beta | 1.9156 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -1.02 | ||
| Volatility % | 36.14 | ||
| 14-Day RSI | 37.45 | ||
| 14-Day ATR (HK$) | 0.158299 | ||
| 20-Day SMA (HK$) | 2.17975 | ||
| 12-1 Month Momentum % | -73.68 | ||
| 52-Week Range (HK$) | 1.82 - 10.02 | ||
| Shares Outstanding (Mil) | 245.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3D Medicines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3D Medicines Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
3D Medicines Inc Frequently Asked Questions
What is 3D Medicines Inc(HKSE:01244)'s stock price today?
The current price of HKSE:01244 is HK$2.02. The 52 week high of HKSE:01244 is HK$10.02 and 52 week low is HK$1.82.
When is next earnings date of 3D Medicines Inc(HKSE:01244)?
The next earnings date of 3D Medicines Inc(HKSE:01244) is .
Does 3D Medicines Inc(HKSE:01244) pay dividends? If so, how much?
3D Medicines Inc(HKSE:01244) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on 3D Medicines Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers